Slit-lamp view of sarcoid uveitis showing mutton-fat keratic precipitates and anterior chamber inflammation in a patient with sarcoidosis.

Sarcoid uveitis is intraocular inflammation caused by sarcoidosis, a systemic granulomatous disease of unknown cause. It typically appears in adults aged 20 to 50 as a chronic granulomatous anterior uveitis with mutton-fat keratic precipitates, though it can also involve the vitreous, retina, and choroid. A chest CT showing hilar lymphadenopathy usually points to the diagnosis, and corticosteroids control most cases.

Case Study

A 38-year-old woman presented with bilateral redness, blurred vision, and photophobia that had worsened over several weeks. She reported dry cough and fatigue but denied fever or weight loss. On slit-lamp examination, she had mutton-fat keratic precipitates, anterior chamber cells, and posterior synechiae.

Fundoscopy revealed perivascular cuffing (“candle wax drippings”) and choroidal granulomas. A chest X-ray showed bilateral hilar lymphadenopathy, and serum angiotensin-converting enzyme (ACE) was elevated. She received a diagnosis of sarcoid uveitis, started systemic corticosteroids and an immunosuppressant, and improved.

What Is Sarcoid Uveitis?

Sarcoid uveitis is uveal tract inflammation associated with systemic sarcoidosis. It may present as anterior, intermediate, posterior, or panuveitis, and it is one of the most common ocular manifestations of the disease. Sometimes the eye is the first organ to declare itself.

Sarcoidosis and uveitis occur together often enough that any chronic granulomatous or bilateral uveitis should prompt a systemic evaluation, even when the patient has no respiratory symptoms. Early diagnosis and treatment prevent glaucoma, cataract, and macular damage.

Test your knowledge 10 questions from this article
Choroida · Fundus imaging

Fundus Explorer Pro

Photograph the retinal findings described here with the phone already in your pocket — 22 D optics and built-in illumination in one handheld unit.

From Choroida — the team behind this site

Pathophysiology

Sarcoidosis begins with an exaggerated T-cell response, probably to an unidentified antigen in a genetically susceptible person. The result is granulomatous inflammation in the eye. Key mechanisms include:

  • Granuloma formation: a T-cell-mediated response produces non-caseating granulomas in the uveal tract.
  • Cytokine release: elevated tumor necrosis factor-alpha (TNF-α) and interleukins perpetuate inflammation.
  • Vascular involvement: granulomatous inflammation around retinal vessels causes perivascular sheathing and ischemia.

How Common Is Sarcoid Uveitis?

Sarcoid uveitis accounts for roughly 3 to 15% of uveitis cases, depending on region and referral pattern. About a quarter to a half of patients with systemic sarcoidosis develop eye disease, and uveitis is its most frequent form.

  • Age: most often 20 to 50 years.
  • Ethnicity: higher prevalence in African American and Scandinavian populations.
  • Sex: slight female predominance.

Sarcoidosis Anterior Uveitis (Sarcoid Iridocyclitis)

Anterior disease is the most common pattern and is usually a chronic granulomatous iridocyclitis, often bilateral. Findings include:

  • Mutton-fat keratic precipitates on the corneal endothelium.
  • Iris nodules: Koeppe nodules at the pupillary margin and Busacca nodules on the stroma.
  • Posterior synechiae, plus trabecular meshwork nodules and tent-shaped peripheral anterior synechiae.

Some patients instead present with a non-granulomatous picture that mimics acute anterior uveitis, so absent mutton-fat precipitates do not rule out sarcoidosis. Intraocular pressure often rises because of trabecular inflammation and synechial angle closure.

Sarcoid Panuveitis, Retinitis, and Retinal Vasculitis

Posterior involvement is less common than anterior disease but causes most of the vision loss. Intermediate uveitis shows vitritis with snowballs and a string-of-pearls arrangement. Periphlebitis produces perivascular exudates, the classic candle wax drippings, and can progress to vein occlusion, ischemia, and neovascularization.

Sarcoid retinitis usually means retinal vasculitis with perivascular infiltrates rather than a true necrotizing retinitis. Choroidal granulomas, optic disc granulomas, and cystoid macular edema also occur. When inflammation involves every layer, the picture is sarcoid panuveitis.

Systemic clues include dry cough, dyspnea, fatigue, and erythema nodosum.

Sarcoid Uveitis

Examination Findings and Imaging

  • Slit lamp: granulomatous anterior chamber inflammation, iris nodules, and synechiae.
  • Fundus: perivascular cuffing, granulomas, and vitreous haze.
  • Fluorescein angiography: highlights retinal vasculitis and leakage; OCT quantifies macular edema.
  • Indocyanine green angiography: shows hypofluorescent choroidal granulomas.
  • Chest imaging: CT or X-ray shows hilar lymphadenopathy.

Peripheral angiography often reveals vasculitis in eyes that look quiet, so image any patient with vitritis or unexplained macular edema.

Sarcoid Uveitis

Differential Diagnosis

Granulomatous and posterior uveitis share a short but important differential:

  • Tuberculous uveitis.
  • Syphilitic uveitis, the great mimicker.
  • Vogt-Koyanagi-Harada (VKH) syndrome.
  • Sympathetic ophthalmia.
  • Behçet disease and multiple sclerosis-associated intermediate uveitis.
  • Idiopathic uveitis, and intraocular lymphoma presenting as steroid-resistant vitritis (see uveitis masquerade syndromes).

How Do You Diagnose Sarcoid Uveitis?

Diagnosis combines the ocular exam with systemic testing. A biopsy showing non-caseating granulomas confirms it, but many patients carry a presumed diagnosis based on International Workshop on Ocular Sarcoidosis (IWOS) criteria, which pair characteristic eye signs with supportive systemic findings.

  • Ocular exam: granulomatous features at the slit lamp and fundus.
  • Chest CT: more sensitive than a plain film for hilar and mediastinal nodes.
  • Labs: serum ACE, lysozyme, and calcium, plus tuberculosis testing and syphilis serology to exclude mimics.
  • Biopsy: accessible tissue such as a conjunctival nodule, skin lesion, lymph node, or lung.

Serum ACE is elevated in roughly 60 to 75% of patients with active sarcoidosis, so a normal level does not exclude the disease and a high level is not specific. Treat ACE as supporting evidence only.

Sarcoid Uveitis Treatment

Sarcoid uveitis treatment controls ocular inflammation and addresses systemic sarcoidosis, often together with a pulmonologist or rheumatologist. The choice depends on which segment is involved:

  • Corticosteroids: topical drops for anterior uveitis; periocular or intravitreal injection for unilateral disease or macular edema; oral prednisone for intermediate, posterior, bilateral, or panuveitis.
  • Immunosuppressants: methotrexate, azathioprine, or mycophenolate mofetil as steroid-sparing agents in refractory or chronic cases.
  • Biologics: TNF-α inhibitors such as infliximab or adalimumab for severe or unresponsive disease, after tuberculosis screening.
  • Adjuncts: cycloplegics for pain and to prevent synechiae, and IOP-lowering drops as needed.

Taper steroids slowly and watch for relapse, since inflammation often returns as the dose falls. Add a steroid-sparing agent early when a patient needs more than a low daily prednisone dose beyond a few months, to limit cataract, glaucoma, and systemic steroid toxicity.

Prognosis

With prompt treatment, sarcoid uveitis has a favorable visual prognosis. Delayed diagnosis or inadequate treatment leads to complications, including:

  • Chronic glaucoma.
  • Cataract formation.
  • Macular edema and permanent vision loss.

Outcomes are worse with posterior involvement, chronic macular edema, and late referral. Patients need long-term follow-up because sarcoidosis relapses and remits.

All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

References


  1. Baughman, R. P., Lower, E. E., & du Bois, R. M. (2003). Sarcoidosis. Lancet, 361(9363), 1111–1118.
  2. James, W. E., & Tiedeman, J. S. (1989). Diagnosis and management of sarcoid uveitis. American Journal of Ophthalmology, 107(5), 559-567.
  3. Herbort, C. P., Rao, N. A., & Mochizuki, M. (2009). International criteria for the diagnosis of ocular sarcoidosis. Ocular Immunology and Inflammation, 17(3), 160–169.
  4. Iannuzzi, M. C., Rybicki, B. A., & Teirstein, A. S. (2007). Sarcoidosis. New England Journal of Medicine, 357(21), 2153–2165.
  5. Rosenbaum, J. T., & Pasadhika, S. (2013). Granulomatous uveitis: Challenges in diagnosis and management. Current Opinion in Rheumatology, 25(1), 1–8.

Test yourself

A few questions straight from this article.

1 / 10 0 correct
  1. Which populations show the highest prevalence of sarcoid uveitis?

Ahmed Ophthalmologist

Writes and reviews the clinical articles on Educate. Every post is checked against peer-reviewed sources before it goes live.